- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Intermagnetics sales boom, profits plateau
Fourth quarter sales by Intermagnetics General rose more than 33% in the quarter ending May 30 to $5.8 million, or 34¢ per diluted share, from $4.4 million, or 26¢ per diluted share, a year earlier. Net sales increased 57% to $59.1 million from $37.7
Fourth quarter sales by Intermagnetics General rose more than 33% in the quarter ending May 30 to $5.8 million, or 34¢ per diluted share, from $4.4 million, or 26¢ per diluted share, a year earlier. Net sales increased 57% to $59.1 million from $37.7 million. Gains were attributed to on-target performance from recently acquired Invivo, a manufacturer of specialty patient monitors.
For fiscal 2004, net income at the Latham, NY, company, excluding acquisition-related charges, was $15.6 million, or 92¢ per diluted share, compared with $15.9 million, or 94¢ per diluted share, excluding one-time items for the previous year. Reported net income for the fiscal year was $14.8 million, or 87¢ per diluted share, compared with $14.9 million, or 88¢ per diluted share in 2003. The first quarter of FY04 was affected by a planned reduction in deliveries of magnet systems to accommodate a strategic enhancement to the company's exclusive supply agreement with Philips Medical Systems. Intermagnetics said overall operations performed at, or slightly above, previously forecasted levels. The year ahead is expected to bring record financial results. The company announced a three-for-two stock split to enhance liquidity of shares.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
